64,858 results on '"Radiation Injuries"'
Search Results
2. RadiatiOn Dose Among Different EndOvascular Procedures: the RODEO Study (RODEO)
- Author
-
Alessandro Sciahbasi, MD, MD, PhD
- Published
- 2024
3. BIO 300 Oral Powder Safety and Pharmacokinetics
- Author
-
United States Department of Defense and Joint Warfighter Medical Research Program
- Published
- 2024
4. Adverse radiation effect versus tumor progression following stereotactic radiosurgery for brain metastases: Implications of radiologic uncertainty.
- Author
-
Capaldi, Dante, Raleigh, David, Vasudevan, Harish, Chew, Jessica, Nakamura, Jean, Sneed, Penny, Boreta, Lauren, Villanueva-Meyer, Javier, Ni, Lisa, Morin, Olivier, Theodosopoulos, Philip, Braunstein, Steve, Ziemer, Benjamin, and Salans, Mia
- Subjects
Adverse radiation effect ,Brain metastases ,Stereotactic radiosurgery ,Humans ,Radiosurgery ,Treatment Outcome ,Retrospective Studies ,Uncertainty ,Brain Neoplasms ,Radiation Injuries - Abstract
BACKGROUND: Adverse radiation effect (ARE) following stereotactic radiosurgery (SRS) for brain metastases is challenging to distinguish from tumor progression. This study characterizes the clinical implications of radiologic uncertainty (RU). METHODS: Cases reviewed retrospectively at a single-institutional, multi-disciplinary SRS Tumor Board between 2015-2022 for RU following SRS were identified. Treatment history, diagnostic or therapeutic interventions performed upon RU resolution, and development of neurologic deficits surrounding intervention were obtained from the medical record. Differences in lesion volume and maximum diameter at RU onset versus resolution were compared with paired t-tests. Median time from RU onset to resolution was estimated using the Kaplan-Meier method. Univariate and multivariate associations between clinical characteristics and time to RU resolution were assessed with Cox proportional-hazards regression. RESULTS: Among 128 lesions with RU, 23.5% had undergone ≥ 2 courses of radiation. Median maximum diameter (20 vs. 16 mm, p 6 and > 12 months in 25% and 7% of cases, respectively. Higher total EQD2 prior to RU onset (HR = 0.45, p = 0.03) and use of MR perfusion (HR = 0.56, p = 0.001) correlated with shorter time to resolution; larger volume (HR = 1.05, p = 0.006) portended longer time to resolution. Most lesions (57%) were diagnosed as ARE. Most patients (58%) underwent an intervention upon RU resolution; of these, 38% developed a neurologic deficit surrounding intervention. CONCLUSIONS: RU resolution took > 6 months in > 25% of cases. RU may lead to suboptimal outcomes and symptom burden. Improved characterization of post-SRS RU is needed.
- Published
- 2024
5. Clinical Observation of Drug Retention Enema in Preventing Acute Radiation-induced Rectal Injury
- Published
- 2024
6. The Effect of Hyperbaric OxygeN Therapy on brEast Cancer Patients With Late Radiation toxicitY - UMBRELLA HONEY Trial (HONEY)
- Author
-
Helena M Verkooijen, Prof. dr.
- Published
- 2024
7. Adipose-Induced Regeneration of Breast Skin to Treat Post-Mastectomy Radiation Injury in Breast Cancer Patients
- Published
- 2024
8. A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression
- Published
- 2024
9. Moving beyond mean heart dose: The importance of cardiac substructures in radiation therapy toxicity.
- Author
-
Bowen Jones, Sarah, Marchant, Tom, Saunderson, Chris, McWilliam, Alan, and Banfill, Kathryn
- Subjects
- *
RADIOTHERAPY treatment planning , *RADIATION injuries , *OVERALL survival , *CARDIOTOXICITY , *RADIOTHERAPY - Abstract
Normal tissue tolerance dose limits to the heart have been established to reduce the risk of radiation‐induced cardiac disease (RICD). Dose constraints have been developed based on either the mean dose delivered to the whole heart (MHD) or the dose delivered to a specific volume, for example, volume of heart receiving equal to or greater than 30 Gy (V30). There is increasing evidence that the impact of thoracic radiation on cardiac morbidity and mortality has been underestimated. Consequently, there is a need to reduce the dose delivered to the heart in radical radiotherapy treatment planning. The pathophysiology of RICD may relate to dose to specific cardiac substructures (CS) rather than the traditionally observed MHD for common toxicities. The MHD or V30 Gy threshold dose rarely represents the true dose delivered to individual CS. Studies have shown the dose to specific areas may be more strongly correlated with overall survival (OS). With advances in modern radiotherapy techniques, it is vital that we develop robust, evidence‐based dose limits for CS, to fully understand and reduce the risk of RICD, particularly in high‐risk populations with cardiac risk factors. The following review will summarise the existing evidence of dose limits to CS, explain how dose limits may vary according to different disease sites or radiation techniques and propose how radiotherapy plans can be optimised to reduce the dose to these CS in clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. In utero exposure to ionizing radiation and metabolic regulation: perspectives for future multi- and trans-generation effects studies.
- Author
-
Grison, Stéphane, Braga-Tanaka, Ignacia III, Baatout, Sarah, and Klokov, Dmitry
- Subjects
- *
IONIZING radiation , *LITERATURE reviews , *RADIATION protection , *EXPOSURE dose , *RADIATION injuries - Abstract
Purpose: The radiation protection community has been particularly attentive to the risks of delayed effects on offspring from low dose or low dose-rate exposures to ionizing radiation. Despite this, the current epidemiologic studies and scientific data are still insufficient to provide the necessary evidence for improving risk assessment guidelines. This literature review aims to inform future studies on multigenerational and transgenerational effects. It primarily focuses on animal studies involving in utero exposure and discusses crucial elements for interpreting the results. These elements include in utero exposure scenarios relative to the developmental stages of the embryo/fetus, and the primary biological mechanisms responsible for transmitting heritable or hereditary effects to future generations. The review addresses several issues within the contexts of both multigenerational and transgenerational effects, with a focus on hereditary perspectives. Conclusions: Knowledge consolidation in the field of Developmental Origins of Health and Disease (DOHaD) has led us to propose a new study strategy. This strategy aims to address the transgenerational effects of in utero exposure to low dose and low dose-rate radiation. Within this concept, there is a possibility that disruption of epigenetic programming in embryonic and fetal cells may occur. This disruption could lead to metabolic dysfunction, which in turn may cause abnormal responses to future environmental challenges, consequently increasing disease risk. Lastly, we discuss methodological limitations in our studies. These limitations are related to cohort size, follow-up time, model radiosensitivity, and analytical techniques. We propose scientific and analytical strategies for future research in this field. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Exploring Memory Systems After Pediatric Posterior Fossa Tumor: From Memory Profile Comparisons in Nonirradiated Versus Irradiated Patients to Episodic Memory Tests Capable of Detecting Radiation-induced Hippocampal Damage.
- Author
-
Baudou, E., Pollidoro, L., Lemesle, B., Maziero, S., Tensaouti, F., Bertozzi, A.I., Cazaux, M., Costes, M., Courbieres, N., Dufour, C., Grill, J., Chaix, Y., Pariente, J., and Laprie, A.
- Subjects
- *
BRAIN physiology , *EPISODIC memory , *RADIATION injuries , *INFRATENTORIAL brain tumors , *CANCER patients , *PEDIATRICS , *LONGITUDINAL method , *CASE-control method , *NEUROPSYCHOLOGICAL tests , *HIPPOCAMPUS (Brain) , *COMPARATIVE studies , *RADIATION doses , *MEMORY disorders , *COGNITION - Abstract
Pediatric posterior fossa tumor (PFT) survivors experience long-term cognitive sequelae, including memory disorders, for which irradiation is one of the main risk factors. The aims of the present study were to (1) explore the profile of impairment in episodic, semantic, working and procedural memory systems in irradiated versus nonirradiated PFT survivors, and (2) test whether an autobiographical questionnaire and a two-phase ecological test (Epireal) assessing episodic memory are more sensitive to radiation-induced hippocampal damage than commonly used tests. A total of 60 participants (22 irradiated PFT survivors, 17 nonirradiated PFT survivors, and 21 controls) were included in the prospective IMPALA study. They all underwent a broad battery of tests assessing the different memory systems in two 2-day sessions 3 weeks apart. We performed between-groups comparisons and analyzed impairment profiles, using -1.65 SD s as a cut-off. For irradiated patients, correlations were calculated between mean radiation doses to key brain structures involved in memory (hippocampus, cerebellum, and striatum) and corresponding memory scores. PBT survivors performed significantly more poorly than controls (p < 0.001) on conventional tests of episodic, semantic and working memory: 64% of irradiated patients and 35% of nonirradiated patients had a deficit in at least two memory systems, with episodic memory impairment being more specific to the irradiated group. Epireal had a larger effect size than the other episodic memory tests, allowing us to detect deficits in a further 18% of irradiated patients. These deficits were correlated with the mean radiation dose to the left hippocampus. Memory impairment is a frequent long-term cognitive sequela in PFT survivors, especially after radiation therapy. New ecological tests of episodic memory that are more sensitive to radiation-induced deficits than conventional tests could yield specific markers of the toxicity of medial temporal lobe irradiation. • 86% of irradiated patients had a deficit in at least one memory system. • 65% of nonirradiated patients had a deficit in at least one memory system. • Episodic memory was specifically impaired in irradiated patients. • Episodic tests were more sensitive to radiation toxicity on the left hippocampus. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Estimated Doses to the Heart, Lungs and Oesophagus and Risks From Typical UK Radiotherapy for Early Breast Cancer During 2015–2023.
- Author
-
Holt, F., Ivanova, A., Wang, Z., Darby, S., Duane, F., Ntentas, G., Oliveros, S., Lavery, B., Shah, K., Eichholz, A., Dodwell, D., and Taylor, C.
- Subjects
- *
HEART disease related mortality , *RISK assessment , *DOSE-response relationship (Radiation) , *BREAST tumors , *RADIATION injuries , *SMOKING , *HEART , *LUNGS , *META-analysis , *SYSTEMATIC reviews , *LUNG tumors , *RADIATION doses , *ESOPHAGUS , *DISEASE risk factors - Abstract
Breast cancer radiotherapy can increase the risks of heart disease, lung cancer and oesophageal cancer. At present, the best dosimetric predictors of these risks are mean doses to the whole heart, lungs and oesophagus, respectively. We aimed to estimate typical doses to these organs and resulting risks from UK breast cancer radiotherapy. A systematic review and meta-analysis was conducted of planned or delivered mean doses to the whole heart, lungs or oesophagus from UK breast cancer radiotherapy in studies published during 2015–2023. Average mean doses were summarised for combinations of laterality and clinical targets. Heart disease and lung cancer mortality risks were then estimated using established models. For whole heart, thirteen studies reported 2893 doses. Average mean doses were higher in left than in right-sided radiotherapy and increased with extent of clinical targets. For left-sided radiotherapy, average mean heart doses were: 2.0 Gy (range 1.2–8.0 Gy) breast/chest wall, 2.7 Gy (range 0.6–5.6 Gy) breast/chest wall with either axilla or supraclavicular nodes and 2.9 Gy (range 1.3–4.7 Gy) breast/chest wall with nodes including internal mammary. For right-sided radiotherapy, average mean heart doses were: 1.0 Gy (range 0.3–1.0 Gy) breast/chest wall and 1.2 Gy (range 1.0–1.4 Gy) breast/chest wall with either axilla or supraclavicular nodes. There were no whole heart dose estimates from right internal mammary radiotherapy. For whole lung, six studies reported 2230 doses. Average mean lung doses increased with extent of targets irradiated: 2.6 Gy (range 1.4–3.0 Gy) breast/chest wall, 3.0 Gy (range 0.9–5.1 Gy) breast/chest wall with either axilla or supraclavicular nodes and 7.1 Gy (range 6.7–10.0 Gy) breast/chest wall with nodes including internal mammary. For whole oesophagus, two studies reported 76 doses. Average mean oesophagus doses increased with extent of targets irradiated: 1.4 Gy (range 1.0–2.0 Gy) breast/chest wall with either axilla or supraclavicular nodes and 5.8 Gy (range 1.9–10.0 Gy) breast/chest wall with nodes including internal mammary. The typical doses to these organs may be combined with dose-response relationships to estimate radiation risks. Estimated 30-year absolute lung cancer mortality risks from modern UK breast cancer radiotherapy for patients irradiated when aged 50 years were 2–6% for long-term continuing smokers, and <1% for non-smokers. Estimated 30-year mortality risks for heart disease were <1%. • Average mean whole organ doses were ∼2 Gy for heart, 3 Gy lung, and 4 Gy oesophagus. • Organ doses increased with increasing targets irradiated. • Estimated absolute 30-year radiation heart disease mortality risks were 0.2%–0.7%. • Equivalent lung cancer risks were 0.2%–0.4% for non-smokers and 2.3%–6.2% for smokers. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Developing an RNA Signature for Radiation Injury Using a Human Liver-on-a-Chip Model.
- Author
-
Martello, Shannon, Ueda, Yuki, Bylicky, Michelle A., Pinney, Jonathan, Dalo, Juan, Scott, Kevin M. K., Aryankalayil, Molykutty J., and Coleman, C. Norman
- Subjects
GENE expression ,RNA sequencing ,LINCRNA ,MESSENGER RNA ,RADIATION injuries - Abstract
Radiation exposure in a therapeutic setting or during a mass casualty event requires improved medical triaging, where the time to delivery and quantity of medical countermeasures are critical to survival. Radiation-induced liver injury (RILI) and fibrosis can lead to death, but clinical symptoms manifest late in disease pathogenesis and there is no simple diagnostic test to determine RILI. Because animal models do not completely recapitulate clinical symptoms, we used a human liver-on-a-chip model to identify biomarkers of RILI. The goals of this study were: 1. to establish a microfluidic liver-on-a-chip device as a physiologically relevant model for studying radiation-induced tissue damage; and 2. to determine acute changes in RNA expression and biological pathway regulation that identify potential biomarkers and mechanisms of RILI. To model functional human liver tissue, we used the Emulate organ-on-a-chip system to establish a co-culture of human liver sinusoidal endothelial cells (LSECs) and hepatocytes. The chips were subject to 0 Gy (sham), 1 Gy, 4 Gy, or 10 Gy irradiation and cells were collected at 6 h, 24 h, or 7 days postirradiation for RNA isolation. To identify significant expression changes in messenger RNA (mRNA) and long non-coding RNA (lncRNA), we performed RNA sequencing (RNASeq) to conduct whole transcriptome analysis. We found distinct differences in expression patterns by time, dose, and cell type, with higher doses of radiation resulting in the most pronounced expression changes, as anticipated. Ingenuity Pathway Analysis indicated significant inhibition of the cell viability pathway 24 h after 10 Gy exposure in LSECs but activation of this pathway in hepatocytes, highlighting differences between cell types despite receiving the same radiation dose. Overall, hepatocytes showed fewer gene expression changes in response to radiation, with only 3 statistically significant differentially expressed genes at 7 days: APOBEC3H, PTCHD4, and GDNF. We further highlight lncRNA of interest including DINO and PURPL in hepatocytes and TMPO-AS1 and PRC-AS1 in LSECs, identifying potential biomarkers of RILI. We demonstrated the potential utility of a human liver-on-a-chip model with primary cells to model organ-specific radiation injury, establishing a model for radiation medical countermeasure development and further biomarker validation. Furthermore, we identified biomarkers that differentiate radiation dose and defined cell-specific targets for potential radiation mitigation therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Bertram "Bert" Walter Maidment Jr., PhD (1947–2024).
- Author
-
DiCarlo, Andrea L., Rios, Carmen I., Taliaferro, Lanyn P., Satyamitra, Merriline M., Cassatt, David R., and Rotrosen, Daniel
- Subjects
IDIOPATHIC pulmonary fibrosis ,COVID-19 pandemic ,LEADERSHIP ,RADIATION injuries ,OCCUPATIONAL roles - Abstract
Bertram "Bert" Walter Maidment Jr., PhD, passed away in 2024 after a long and successful career in the field of radiation research. He had a PhD in Experimental Pathology and worked in biomedical device development, startup companies, industry, and government service. He played a significant role in the establishment of the Radiation and Nuclear Countermeasures Program (RNCP) within the National Institutes of Health (NIH), where he oversaw the development and licensure of medical countermeasures for radiation public health emergencies. Bert was known for his maverick approach, leadership, and ability to bring parties together. He was also a mentor and advocate for young scientists and made significant contributions to the field of radiation research. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
15. Mitigation of Fetal Radiation Injury from Mid-Gestation Total-body Irradiation by Maternal Administration of Mitochondrial-Targeted GS-Nitroxide JP4-039.
- Author
-
Wu, Yijen L., Christodoulou, Anthony G., Beumer, Jan H., Rigatti, Lora H., Fisher, Renee, Ross, Mark, Watkins, Simon, Cortes, Devin R. E., Ruck, Cody, Manzoor, Shanim, Wyman, Samuel K., Stapleton, Margaret C., Goetzman, Eric, Bharathi, Sivakama, Wipf, Peter, Wang, Hong, Tan, Tuantuan, Christner, Susan M., Guo, Jianxia, and Lo, Cecilia W. Y.
- Subjects
RADIATION injuries ,CEREBRAL hemorrhage ,IONIZING radiation ,MAGNETIC resonance imaging ,RADIATION exposure ,FETAL brain - Abstract
Victims of a radiation terrorist event will include pregnant women and unborn fetuses. Mitochondrial dysfunction and oxidative stress are key pathogenic factors of fetal radiation injury. The goal of this preclinical study is to investigate the efficacy of mitigating fetal radiation injury by maternal administration of the mitochondrial-targeted gramicidin S (GS)-nitroxide radiation mitigator JP4-039. Pregnant female C57BL/6NTac mice received 3 Gy total-body irradiation (TBI) at mid-gestation embryonic day 13.5 (E13.5). Using novel time- and-motion-resolved 4D in utero magnetic resonance imaging (4D-uMRI), we found TBI caused extensive injury to the fetal brain that included cerebral hemorrhage, loss of cerebral tissue, and hydrocephalus with excessive accumulation of cerebrospinal fluid (CSF). Histopathology of the fetal mouse brain showed broken cerebral vessels and elevated apoptosis. Further use of novel 4D Oxy-wavelet MRI capable of probing in vivo mitochondrial function in intact brain revealed a significant reduction of mitochondrial function in the fetal brain after 3 Gy TBI. This was validated by ex vivo Oroboros mitochondrial respirometry. One day after TBI (E14.5) maternal administration of JP4-039, which passes through the placenta, significantly reduced fetal brain radiation injury and improved fetal brain mitochondrial respiration. Treatment also preserved cerebral brain tissue integrity and reduced cerebral hemorrhage and cell death. JP4-039 administration following irradiation resulted in increased survival of pups. These findings indicate that JP4-039 can be deployed as a safe and effective mitigator of fetal radiation injury from mid-gestational in utero ionizing radiation exposure. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Mitigating Viral Impact on the Radiation Response of the Lung.
- Author
-
Groves, Angela M., Paris, Nicole D., Johnston, Carl J., Hernady, Eric, Finkelstein, Jacob, Lawrence, Paige, and Marples, Brian
- Subjects
ACE inhibitors ,RADIATION injuries ,ALVEOLAR macrophages ,VIRUS diseases ,CHEMOKINE receptors - Abstract
Inflammation is a key factor in both influenza and radiation-induced lung pathophysiology. This implies a commonality of response to pulmonary damage from these insults and suggests exacerbated pathology may occur after combined exposure. We therefore tested the hypothesis that past inflammation from viral infection alters the lung microenvironment and lowers tolerance for radiation injury. Mice were inoculated with influenza A virus (IAV) and three weeks later, after virus clearance, mice received total-body irradiation (TBI). Survival as well as systemic and local lung inflammation were assessed, and strategies to mitigate pulmonary injury were investigated. After IAV infection alone, body condition recovered within 3 weeks, however inflammatory pathways remained active for 15 weeks. IAV infection exacerbated subsequent TBI responses, evident by increased lethality, enhanced histologically evident lung injury and an altered lung macrophage phenotype. To mitigate this enhanced sensitivity, captopril [an angiotensin converting enzyme inhibitor (ACEi)] was administered to limit tissue inflammation, or inflammatory monocyte-derived macrophage recruitment was blocked with a C-C chemokine receptor type 2 (CCR2) inhibitor. Both treatments abrogated the changes in circulating immune cells observed 4 weeks after TBI, and attenuated pro-inflammatory phenotypes in lung alveolar macrophages, appearing to shift immune cell dynamics towards recovery. Histologically apparent lung injury was not improved by either treatment. We show that latent lung injury from viral infection exacerbates radiation morbidity and mortality. Although strategies that attenuate proinflammatory immune cell phenotypes can normalize macrophage dynamics, this does not fully mitigate lung injury. Recognizing that past viral infections can enhance lung radiosensitivity is of critical importance for patients receiving TBI, as it could increase the incidence of adverse outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Effect of Age at Time of Irradiation, Sex, Genetic Diversity, and Granulopoietic Cytokine Radiomitigation on Lifespan and Lymphoma Development in Murine H-ARS Survivors.
- Author
-
Plett, P. Artur, Chua, Hui Lin, Wu, Tong, Sampson, Carol H., Guise, Theresa A., Wright, Laura, Pagnotti, Gabriel M., Feng, Hailin, Chin-Sinex, Helen, Pike, Francis, Cox, George N., MacVittie, Thomas J., Sandusky, George, and Orschell, Christie M.
- Subjects
NATURAL history ,RADIATION injuries ,YOUNG adults ,RADIATION exposure ,RADIATION damage - Abstract
Acute, high-dose radiation exposure results in life-threatening acute radiation syndrome (ARS) and debilitating delayed effects of acute radiation exposure (DEARE). The DEARE are a set of chronic multi-organ illnesses that can result in early death due to malignancy and other diseases. Animal models have proven essential in understanding the natural history of ARS and DEARE and licensure of medical countermeasures (MCM) according to the FDA Animal Rule. Our lab has developed models of hematopoietic (H)-ARS and DEARE in inbred C57BL/6J and Jackson Diversity Outbred (JDO) mice of both sexes and various ages and have used these models to identify mechanisms of radiation damage and effective MCMs. Herein, aggregate data from studies conducted over decades in our lab, consisting of 3,250 total-body lethally irradiated C57BL/6J young adult mice and 1,188 H-ARS survivors from these studies, along with smaller datasets in C57BL/6J pediatric and geriatric mice and JDO mice, were examined for lifespan and development of thymic lymphoma in survivors up to 3 years of age. Lifespan was found to be significantly shortened in H-ARS survivors compared to age-matched nonirradiated controls in all four models. Males and females exhibited similar lifespans except in the young adult C57BL/ 6J model where males survived longer than females after 16 months of age. The incidence of thymic lymphoma was increased in H-ARS survivors from the young adult and pediatric C57BL/ 6J models. Consistent with our findings in H-ARS, geriatric mice appeared more radioresistant than other models, with a lifespan and thymic lymphoma incidence more similar to nonirradiated controls than other models. Increased levels of multiple pro-inflammatory cytokines in DEARE bone marrow and serum correlated with shortened lifespan and malignancy, consistent with other animal models and human data. Of interest, G-CSF levels in bone marrow and serum 8-11 months after irradiation were significantly increased in females. Importantly, treatment with granulopoietic cytokine MCM for radiomitigation of H-ARS did not influence the long-term survival rate or incidence of thymic lymphoma in any model. Taken together, these findings indicate that the lifespan of H-ARS survivors was significantly decreased regardless of age at time of exposure or genetic diversity, and was unaffected by earlier treatment with granulopoietic cytokines for radiomitigation of H-ARS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Selecting the Most Relevant Mouse Strains for Evaluating Radiation-Induced Multiple Tissue Injury after Leg-Shielded Partial-Body Gamma Irradiation.
- Author
-
Down, Julian D., Cornwall-Brady, Milton R., Huang, Wei, Hurwitz, Martina, Floyd, Scott R., and Yilmaz, Omer H.
- Subjects
RADIATION injuries ,IONIZING radiation ,GAMMA rays ,RADIATION exposure ,HINDLIMB ,LUNGS - Abstract
Animal studies are needed that best simulate a large-scale, inhomogeneous body exposure after a radiological or nuclear incident and that provides a platform for future development of medical countermeasures. A partial-body irradiation (PBI) model using
137 Cs gamma rays with hind limb (tibia) shielding was developed and assessed for the sequalae of radiation injuries to gastrointestinal tract, bone marrow (BM) and lung and among different genetic mouse strains (C57BL/6J, C57L/J, CBA/J and FVB/NJ). In this case, a marginal level of BM shielding (∼2%) provided adequate protection against lethality from infection and hemorrhage and enabled escalation of radiation doses with evaluation of both acute and delayed radiation syndromes. A steep radiation dose-dependent body weight loss was observed over the first 5 days attributed to enteritis with C57BL/6J mice appearing to be the most sensitive strain. Peripheral blood cell analysis revealed significant depression and recovery of leukocytes and platelets over the first month after PBI and were comparable among the four different mouse strains. Latent pulmonary injury was observed on micro-CT imaging at 4 months in C57L/J mice and confirmed histologically as severe pneumonitis that was lethal at 12 Gy. The lethality and radiological densitometry (HUs) dose responses were comparable to previous studies on C57L/J mice after total-body irradiation (TBI) and BM transplant rescue as well as after localized whole-thorax irradiation (WTI). Indeed, the lethal radiation doses and latency appeared similar for pneumonitis appearing in rhesus macaques after WTI or PBI as well as predicted for patients given systemic radiotherapy. In contrast, PBI treatment of C57BL/6 mice at a higher dose of 14 Gy had far longer survival times and developed extreme and debilitating pIeural effusions; an anomaly as similarly reported in previous thorax irradiation studies on this mouse strain. In summary, a radiation exposure model that delivers PBI to unanesthetized mice in a device that provides consistent shielding of the hind limb BM was developed for137 Cs gamma rays with physical characteristics and relevance to relatively high photon energies expected from the detonation of a nuclear device or accidental release of ionizing radiation. Standard strains such as C57BL/6J mice may be used reliably for early GI or hematological radiation syndromes while the C57L/J mouse strain stands out as the most appropriate for evaluating the delayed pulmonary effects of acute radiation exposure and recapitulating this disease in humans. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
19. Reducing computed tomography (CT) imaging for adults with minor traumatic brain injuries in the emergency department.
- Author
-
Rowe, Brian H., Yang, Esther, Corrick, Shaina, and Hussain, M. Wasif
- Subjects
MEDICAL care use ,PATIENT education ,PATIENTS ,COMPUTED tomography ,BRAIN ,RADIATION injuries ,CLINICAL decision support systems ,HOSPITAL emergency services ,EMERGENCY medical services ,DIAGNOSTIC errors ,DECISION making in clinical medicine ,ATTITUDE (Psychology) ,ALLIED health personnel ,ORGANIZATIONAL change ,MEDICAL radiology ,COMMUNICATION ,PATIENT-professional relations ,BRAIN injuries ,EVIDENCE-based medicine ,CHANGE ,MEDICAL care costs ,DISEASE risk factors ,ADULTS - Published
- 2024
- Full Text
- View/download PDF
20. A bibliometric analysis of radiation-induced brain injury: a research of the literature from 1998 to 2023.
- Author
-
Lan, Jinxin, Ren, Yifan, Liu, Yuyang, Chen, Ling, and Liu, Jialin
- Subjects
BIBLIOMETRICS ,BRAIN injuries ,BRAIN research ,RADIATION injuries ,CLUSTER analysis (Statistics) - Abstract
Background: Radiation-induced brain injury (RIBI) is a debilitating sequela after cranial radiotherapy. Research on the topic of RIBI has gradually entered the public eye, with more innovations and applications of evidence-based research and biological mechanism research in the field of that. This was the first bibliometric analysis on RIBI, assessing brain injury related to radiation articles that were published during 1998–2023, to provide an emerging theoretical basis for the future development of RIBI. Methods: Literature were obtained from the Web of Science Core Collection (WOSCC) from its inception to December 31, 2023. The column of publications, author details, affiliated institutions and countries, publication year, and keywords were also recorded. Results: A total of 2543 journal articles were selected. The annual publications on RIBI fluctuated within a certain range. Journal of Neuro-oncology was the most published journal and Radiation Oncology was the most impactful one. LIMOLI CL was the most prolific author with 37 articles and shared the highest h-index with BARNETT GH. The top one country and institutions were the USA and the University of California System, respectively. Clusters analysis of co-keywords demonstrated that the temporal research trends in this field primarily focused on imaging examination and therapy for RIBI. Conclusion: This study collects, visualizes, and analyzes the literature within the field of RIBI over the last 25 years to map the development process, research frontiers and hotspots, and cutting-edge directions in clinical practice and mechanisms related to RIBI. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Balanced Duality: H 2 O 2 -Based Therapy in Cancer and Its Protective Effects on Non-Malignant Tissues.
- Author
-
Zaher, Amira, Petronek, Michael S., Allen, Bryan G., and Mapuskar, Kranti A.
- Subjects
- *
CANCER chemotherapy , *SUPEROXIDE dismutase , *RADIATION injuries , *REACTIVE oxygen species , *HYDROGEN peroxide - Abstract
Conventional cancer therapy strategies, although centered around killing tumor cells, often lead to severe side effects on surrounding normal tissues, thus compromising the chronic quality of life in cancer survivors. Hydrogen peroxide (H2O2) is a secondary signaling molecule that has an array of functions in both tumor and normal cells, including the promotion of cell survival pathways and immune cell modulation in the tumor microenvironment. H2O2 is a reactive oxygen species (ROS) crucial in cellular homeostasis and signaling (at concentrations maintained under nM levels), with increased steady-state levels in tumors relative to their normal tissue counterparts. Increased steady-state levels of H2O2 in tumor cells, make them vulnerable to oxidative stress and ultimately, cell death. Recently, H2O2-producing therapies—namely, pharmacological ascorbate and superoxide dismutase mimetics—have emerged as compelling complementary treatment strategies in cancer. Both pharmacological ascorbate and superoxide dismutase mimetics can generate excess H2O2 to overwhelm the impaired H2O2 removal capacity of cancer cells. This review presents an overview of H2O2 metabolism in the physiological and malignant states, in addition to discussing the anti-tumor and normal tissue-sparing mechanism(s) of, and clinical evidence for, two H2O2-based therapies, pharmacological ascorbate and superoxide dismutase mimetics. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Differential Remodeling of the Oxylipin Pool After FLASH Versus Conventional Dose-Rate Irradiation In Vitro and In Vivo.
- Author
-
Portier, Lucie, Daira, Patricia, Fourmaux, Baptiste, Heinrich, Sophie, Becerra, Margaux, Fouillade, Charles, Berthault, Nathalie, Dutreix, Marie, Londoño-Vallejo, Arturo, Verrelle, Pierre, Bernoud-Hubac, Nathalie, and Favaudon, Vincent
- Subjects
- *
OMEGA-6 fatty acids , *RADIATION injuries , *LIQUID chromatography-mass spectrometry , *FREE radical reactions , *UNSATURATED fatty acids - Abstract
The products of lipid peroxidation have been implicated in human diseases and aging. This prompted us to investigate the response to conventional (CONV) versus FLASH irradiation of oxylipins, a family of bioactive lipid metabolites derived from omega-3 or omega-6 polyunsaturated fatty acids through oxygen-dependent non-enzymatic as well as dioxygenase-mediated free radical reactions. Ultrahigh performance liquid chromatography coupled to tandem mass spectrometry was used to quantify the expression of 37 oxylipins derived from eicosatetraenoic, eicosapentaenoic and docosahexaenoic acid in mouse lung and in normal or cancer cells exposed to either radiation modality under precise monitoring of the temperature and oxygenation. Among the 37 isomers assayed, 14-16 were present in high enough amount to enable quantitative analysis. The endpoints were the expression of oxylipins as a function of the dose of radiation, normoxia versus hypoxia, temperature and post-irradiation time. In normal, normoxic cells at 37°C radiation elicited destruction and neosynthesis of oxylipins acting antagonistically on a background subject to rapid remodeling by oxygenases. Neosynthesis was observed in the CONV mode only, in such a way that the level of oxylipins at 5 minutes after FLASH irradiation was 20-50% lower than in non-irradiated and CONV-irradiated cells. Hypoxia mitigated the differential CONV versus FLASH response in some oxylipins. These patterns were not reproduced in tumor cells. Depression of specific oxylipins following FLASH irradiation was observed in mouse lung at 5 min following irradiation, with near complete recovery in 24 hours and further remodeling at one week and two months post-irradiation. Down-regulation of oxylipins was a hallmark of FLASH irradiation specific of normal cells. Temperature effects suggest that this process occurs via diffusion-controlled, bimolecular recombination of a primary radical species upstream from peroxyl radical formation and evoke a major role of the membrane composition and fluidity in response to the FLASH modality. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Serum miR-192–5p is a promising biomarker for lethal radiation injury.
- Author
-
Jia, Meng, Wang, Zhanyu, Liu, Xin, Zhang, Hong, Fan, Ying, Cai, Dan, Li, Yaqiong, Shen, Liping, Wang, Zhidong, Wang, Qi, and Qi, Zhenhua
- Subjects
- *
PEARSON correlation (Statistics) , *GENE expression , *RADIATION injuries , *LYMPHOCYTE count , *IONIZING radiation , *NUCLEAR accidents - Abstract
In the event of a nuclear or radiation accident, rapid identification is required for those who exposed to potentially lethal dose irradiation. However, existing techniques are not adequate for the classification of lethal injury. Several studies have explored the potential of miRNAs as biomarkers for ionizing radiation injury, however, there are few miRNAs with specific expression for lethal radiation injury. Therefore, the aim of this study was to screen and validate the possibility of serum miRNAs as biomarkers of lethal radiation injury. We found the specific expression of mmu-miR-374c–5p / mmu-miR-194–5p on first day and mmu-miR-192–5p / mmu-miR-223–3p on third day in the mouse serum only under 10 Gy irradiation by miRNA sequencing and all significantly correlated with lymphocyte counts by Pearson's correlation analysis. In addition, it was found that among the 4 candidate serum miRNAs, only highly-expressed mmu-miR-192–5p in mouse serum irradiated at lethal doses was returned to sham-like expression levels at 3 days post-irradiation with amifostine pretreatment and closely correlated with survival rate. We demonstrated for the first time that mmu-miR-192–5p screened from lethally irradiated mice sera can be used as a potential biomarker for lethal irradiation injury, which will be helpful to improve efficiency of medical treatment to minimize casualties after a large-scale nuclear accident. • mmu-miR-374c-5p, mmu-miR-194–5p, mmu-miR-192–5p and mmu-miR-223–3p was specially expressed only under lethal irradiation. • mmu-miR-192–5p was significantly increased on third day only after lethal irradiation. • mmu-miR-192–5p expression was negatively correlated with lymphocyte counts. • mmu-miR-192–5p expression could return to sham-like level on third day post-irradiation with amifostine pretreatment. • mmu-miR-192–5p expression was related to the ability to survive (or the degree of damage suffered). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. FG‐4592 protected haematopoietic system from ionising radiation in mice.
- Author
-
Wang, Yuedong, Cheng, Ying, Zhang, Pei, Huang, Daqian, Zhai, Xuanlu, Feng, Zhenlan, Fang, Duo, Liu, Cong, Du, Jicong, and Cai, Jianming
- Subjects
- *
HEMATOPOIETIC system , *BONE marrow cells , *PROLINE hydroxylase , *BONE marrow , *BLOOD cells , *RADIATION injuries - Abstract
Ionising radiation exposure can lead to acute haematopoietic radiation syndrome. Despite significant advancements in the field of radioprotection, no drugs with high efficacy and low toxicity have yet been approved by the Food and Drug Administration. FG‐4592, as a proline hydroxylase inhibitor, may play an important role in radioprotection of the haematopoietic system. Mice were peritoneal injected with FG‐4592 or normal saline. After irradiation, the survival time, body weight, peripheral blood cell and bone marrow cell (BMC) count, cell apoptosis, pathology were analysed and RNA‐sequence technique (RNA‐Seq) was conducted to explore the mechanism of FG‐4592 in the haematopoietic system. Our results indicated that FG‐4592 improved the survival rate and weight of irradiated mice and protected the spleen, thymus and bone marrow from IR‐induced injury. The number of BMCs was increased and protected against IR‐induced apoptosis. FG‐4592 also promoted the recovery of the blood system and erythroid differentiation. The results of RNA‐Seq and Western blot showed that the NF‐κB signalling pathway and hypoxia‐inducible factor‐1 (HIF‐1) signalling pathway were upregulated by FG‐4592. Meanwhile, RT‐PCR results showed that FG‐4592 could promote inflammatory response significantly. FG‐4592 exhibited radioprotective effects in the haematopoietic system by promoting inflammatory response and targeting the NF‐κB, HIF signalling pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Radiomics for clinical decision support in radiation oncology.
- Author
-
Russo, L., Charles-Davies, D., Bottazzi, S., Sala, E., and Boldrini, L.
- Subjects
- *
TUMOR diagnosis , *RADIOTHERAPY , *MEDICAL quality control , *RADIOMICS , *CLINICAL decision support systems , *CANCER patient medical care , *RADIATION injuries , *ONCOLOGY , *DECISION making in clinical medicine , *TUMOR markers , *RADIATION dosimetry , *TUMORS , *RADIATION doses - Abstract
Radiomics is a promising tool for the development of quantitative biomarkers to support clinical decision-making. It has been shown to improve the prediction of response to treatment and outcome in different settings, particularly in the field of radiation oncology by optimising the dose delivery solutions and reducing the rate of radiation-induced side effects, leading to a fully personalised approach. Despite the promising results offered by radiomics at each of these stages, standardised methodologies, reproducibility and interpretability of results are still lacking, limiting the potential clinical impact of these tools. In this review, we briefly describe the principles of radiomics and the most relevant applications of radiomics at each stage of cancer management in the framework of radiation oncology. Furthermore, the integration of radiomics into clinical decision support systems is analysed, defining the challenges and offering possible solutions for translating radiomics into a clinically applicable tool. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. An Overview of Radiation Countermeasure Development in Radiation Research from 1954 to 2024.
- Author
-
Kiang, Juliann G., Cannon, Georgetta, and Singh, Vijay K.
- Subjects
RADIATION injuries ,NUCLEAR warfare ,RADIATION exposure ,CLINICAL indications ,CELLULAR signal transduction - Abstract
Preparation for medical responses to major radiation accidents, further driven by increases in the threat of nuclear warfare, has led to a pressing need to understand the underlying mechanisms of radiation injury (RI) alone or in combination with other trauma (combined injury, CI). The identification of these mechanisms suggests molecules and signaling pathways that can be targeted to develop radiation medical countermeasures. Thus far, the United States Food and Drug Administration (U.S. FDA) has approved seven countermeasures to mitigate hematopoietic acute radiation syndrome (H-ARS), but no drugs are available for prophylaxis and no agents have been approved to combat the other sub-syndromes of ARS, let alone delayed effects of acute radiation exposure or the effects of combined injury. From its inception, Radiation Research has significantly contributed to the understanding of the underlying mechanisms of radiation injury and combined injury, and to the development of radiation medical countermeasures for these indications through the publication of peer-reviewed research and review articles. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Radiation Research Society Journal-based Historical Review of the Use of Biomarkers for Radiation Dose and Injury Assessment: Acute Health Effects Predictions.
- Author
-
Blakely, William F., Port, Matthias, Ostheim, Patrick, and Abend, Michael
- Subjects
BLOOD cell count ,CHROMOSOME abnormalities ,CHROMOSOMAL translocation ,RADIATION exposure ,RADIATION injuries - Abstract
A multiple-parameter based approach using radiation-induced clinical signs and symptoms, hematology changes, cytogenetic chromosomal aberrations, and molecular biomarkers changes after radiation exposure is used for biodosimetry-based dose assessment. In the current article, relevant milestones from Radiation Research are documented that forms the basis of the current consensus approach for diagnostics after radiation exposure. For example, in 1962 the use of cytogenetic chromosomal aberration using the lymphocyte metaphase spread dicentric assay for biodosimetry applications was first published in Radiation Research. This assay is now complimented using other cytogenetic chromosomal aberration assays (i.e., chromosomal translocations, cytokinesis-blocked micronuclei, premature chromosome condensation, γ-H2AX foci, etc.). Changes in blood cell counts represent an early-phase biomarker for radiation exposures. Molecular biomarker changes have evolved to include panels of organ-specific plasma proteomic and blood-based gene expression biomarkers for radiation dose assessment. Maturation of these assays are shown by efforts for automated processing and scoring, development of point-of-care diagnostics devices, service laboratories inter-comparison exercises, and applications for dose and injury assessments in radiation accidents. An alternative and complementary approach has been advocated with the focus to de-emphasize "dose" and instead focus on predicting acute or delayed health effects. The same biomarkers used for dose estimation (e.g., lymphocyte counts) can be used to directly predict the later developing severity degree of acute health effects without performing dose estimation as an additional or intermediate step. This review illustrates contributing steps toward these developments published in Radiation Research. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Neonatal Thyrotoxicosis in Infants of Mothers with Graves' Disease Treated for Radioiodine-Induced Hypothyroidism: A Literature Review.
- Author
-
Jankovski, Lucia, Grosek, Štefan, Žerjav, Mojca Tanšek, Šimic, Marijana Vidmar, and Zaletel, Katja
- Subjects
RISK assessment ,MEDICAL history taking ,IODINE radioisotopes ,MATERNAL health services ,THYROID gland function tests ,IMMUNOGLOBULINS ,RADIATION injuries ,HYPERTHYROIDISM ,FETAL monitoring ,GRAVES' disease ,PREGNANCY complications ,THYROTROPIN ,HYPOTHYROIDISM ,DISEASE risk factors ,DISEASE complications ,CHILDREN ,PREGNANCY - Abstract
Fetal and neonatal thyrotoxicosis occurs in up to 5% of pregnancies in mothers with Graves' disease (GD). This condition is caused by stimulating antibodies against the thyrotropin receptor (TRAbs) that cross the placenta and may stimulate the fetal thyroid, typically in the second half of pregnancy. GD is often treated with radioiodine, resulting in hypothyroidism in most patients, but TRAbs can persist for several years. Even if a pregnant mother is hypothyroid after radioiodine therapy or surgery, her TRAbs can still, although rarely, induce fetal hyperthyroidism. In this review, we first present two cases of neonatal hyperthyroidism in mothers with GD who became hypothyroid after prior radioiodine therapy, identified through a 10-year analysis of the National Perinatal System in Slovenia. Based on these cases, we provide an overview of existing data on this rare clinical condition in neonates. We also discuss the underlying mechanisms and clinical outcomes based on currently available data. In conclusion, our review highlights the importance of careful monitoring during pregnancy in all women with GD, even in those well managed after radioiodine therapy or surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Acute radiation skin injury in stage III-IV head and neck cancer: scale correlates and predictive model.
- Author
-
Zhou, Zihan, Lin, Junjian, Wang, Ying, Chen, Yunhao, Zhang, Yang, Ding, Xingchen, and Xu, Benhua
- Subjects
- *
HEAD & neck cancer , *RADIATION injuries , *SKIN injuries , *INTENSITY modulated radiotherapy , *LEUKOCYTE count - Abstract
Purpose: Active radiation skin injury (ARSI) has the highest incidence of acute adverse reactions caused by radiotherapy (RT) in patients with head and neck cancer (HNC). This study aimed to screen risk factors that can facilitate the identification of HNC patients at high risk of ARSI. Methods: Data from 255 stage III-IV HNC patients who underwent intensity-modulated radiation therapy (IMRT) were collected. The data from our medical records, including clinical characteristics and hematological indices before RT, were retrospectively collected and arranged. The Common Terminology Criteria for Adverse Events Criteria (CTCAE), Radiation Therapy Oncology Group Criteria (RTOG), World Health Organization Criteria (WHO), Oncology Nursing Society (ONS), Acute Radiation Dermatitis Graduation Scale, Douglas & Fowler and Radiation Dermatitis Severity Scale (RDSS) were used to assess ARSI. Of these, CTCAE was used for further analysis. Binary logistic regression analyses were used to identity risk factors. To establish the correction between each risk factor and the ARSI score, the odds ratio (OR) and 95% confidence interval (CI) were computed. Results: The assessment results of the CTCAE with RTOG, WHO, ONS, Graduation Scale, Douglas & Fowler and RDSS have good consistency. After radiotherapy, 18.4% of patients had at least 3 (3 +) grade ARSI. Multivariate logistic regression analysis revealed that the KPS score, blood glucose level, white blood cell count, and plasma free thyroxine (FT4) concentration were independent risk factors for 3 + grade ARSI. A nomogram was constructed on the basis of these risk factors, which demonstrated good predictive power according to the area under the ROC curve (AUC). The satisfactory consistency and clinical efficacy of the nomogram were confirmed by calibration curves and decision curve analysis (DCA). Conclusion: A low KPS score, high blood glucose level, high white blood cell count, and high thyroid hormone prior to radiotherapy for stage III-IV HNC are independent risk factors for grade 3 + RSI. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Insights into ionizing radiation-induced bone marrow hematopoietic stem cell injury.
- Author
-
Zhang, Yimin, Chen, Xinliang, Wang, Xinmiao, Chen, Jun, Du, Changhong, Wang, Junping, and Liao, Weinian
- Subjects
- *
HEMATOPOIETIC stem cells , *BONE marrow , *RADIATION injuries , *IONIZING radiation , *WOUNDS & injuries , *RADIOBIOLOGY - Abstract
With the widespread application of nuclear technology across various fields, ionizing radiation-induced injuries are becoming increasingly common. The bone marrow (BM) hematopoietic tissue is a primary target organ of radiation injury. Recent researches have confirmed that ionizing radiation-induced hematopoietic dysfunction mainly results from BM hematopoietic stem cells (HSCs) injury. Additionally, disrupting and reshaping BM microenvironment is a critical factor impacting both the injury and regeneration of HSCs post radiation. However, the regulatory mechanisms of ionizing radiation injury to BM HSCs and their microenvironment remain poorly understood, and prevention and treatment of radiation injury remain the focus and difficulty in radiation medicine research. In this review, we aim to summarize the effects and mechanisms of ionizing radiation-induced injury to BM HSCs and microenvironment, thereby enhancing our understanding of ionizing radiation-induced hematopoietic injury and providing insights for its prevention and treatment in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Prospective Randomized Phase 2 Trial of Hypofractionated Stereotactic Radiation Therapy of 25 Gy in 5 Fractions Compared With 35 Gy in 5 Fractions in the Reirradiation of Recurrent Glioblastoma.
- Author
-
Chen, Andre Tsin Chih, Serante, Alexandre Ruggieri, Ayres, Aline Sgnolf, Tonaki, Juliana Ono, Moreno, Raquel Andrade, Shih, Helen, Gattás, Gabriel Scarabotolo, Lopez, Rossana Veronica Mendoza, dos Santos de Jesus, Gabriela Reis, de Carvalho, Icaro Thiago, Marotta, Rodrigo Carvalho, Marta, Gustavo Nader, Feher, Olavo, Neto, Hugo Sterman, Ribeiro, Iuri Santana Neville, Vasconcelos, Karina Gondim Moutinho da Conceição, Figueiredo, Eberval Gadelha, and Weltman, Eduardo
- Subjects
- *
DOSE fractionation , *GLIOBLASTOMA multiforme , *RADIOTHERAPY , *OVERALL survival , *PROGRESSION-free survival , *CANCER invasiveness , *RADIATION injuries - Abstract
The aim of this work was to investigate whether reirradiation of recurrent glioblastoma with hypofractionated stereotactic radiation therapy (HSRT) consisting of 35 Gy in 5 fractions (35 Gy/5 fx) compared with 25 Gy in 5 fractions (25 Gy/5 fx) improves outcomes while maintaining acceptable toxicity. We conducted a prospective randomized phase 2 trial involving patients with recurrent glioblastoma (per the 2007 and 2016 World Health Organization classification). A minimum interval from first radiation therapy of 5 months and gross tumor volume of 150 cc were required. Patients were randomized 1:1 to receive HSRT alone in 25 Gy/5 fx or 35 Gy/5 fx. The primary endpoint was progression-free survival (PFS). We used a randomized phase 2 screening design with a 2-sided α of 0.15 for the primary endpoint. From 2011 to 2019, 40 patients were randomized and received HSRT, with 20 patients in each group. The median age was 50 years (range, 27-71); a new resection before HSRT was performed in 75% of patients. The median PFS was 4.9 months in the 25 Gy/5 fx group and 5.2 months in the 35 Gy/5 fx group (P =.23). Six-month PFS was similar at 40% (85% CI, 24%-55%) for both groups. The median overall survival (OS) was 9.2 months in the 25 Gy/5 fx group and 10 months in the 35 Gy/5 fx group (P =.201). Grade ≥3 necrosis was numerically higher in the 35 Gy/5 fx group (3 [16%] vs 1 [5%]), but the difference was not statistically significant (P =.267). In an exploratory analysis, median OS of patients who developed treatment-related necrosis was 14.1 months, and that of patients who did not was 8.7 months (P =.003). HSRT alone with 35 Gy/5 fx was not superior to 25 Gy/5 fx in terms of PFS or OS. Due to a potential increase in the rate of clinically meaningful treatment-related necrosis, we suggest 25 Gy/5 fx as the standard dose in HSRT alone. During follow-up, attention should be given to differentiating tumor progression from potentially manageable complications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Pattern of Expression of MicroRNA in Patients with Radiation-Induced Bladder Injury.
- Author
-
Nakamura, Ko, Ohno, Takaya, Inamoto, Teruo, Takai, Tomoaki, Uchimoto, Taizo, Fukushima, Tatsuo, Nishimura, Kazuki, Yano, Yusuke, Nishio, Kyosuke, Kinoshita, Shoko, Matsunaga, Tomohisa, Nakamori, Keita, Tsutsumi, Takeshi, Tsujino, Takuya, Uehara, Hirofumi, Komura, Kazumasa, Takahara, Kiyoshi, and Azuma, Haruhito
- Subjects
- *
DATA analysis , *MICRORNA , *RADIATION injuries , *RADIATION , *RETROSPECTIVE studies , *TUMOR suppressor genes , *LOG-rank test , *BLADDER , *STATISTICS , *SURVIVAL analysis (Biometry) , *PROPORTIONAL hazards models - Abstract
Introduction: Bladder cancer (BC) is sensitive to radiation treatment and a subset of patients experience radiation-induced injuries including shrinkage of bladder due to bladder fibrosis. Methods: This study is a retrospective cohort study. Three Japanese BC patients were randomly selected. Using a microRNA (miRNA) array, comparing their samples with or without radiation-induced injuries, we have checked the clustering of miRNA expression. Results: Hsa-miR-130a, hsa-miR-200c, hsa-miR-141, and hsa-miR-96 were found to be highly expressed (>50 times) in patients with fibrotic bladder shrinkage (FBS) compared to those with intact bladder (IB) function. In patients with FBS, hsa-miR-6835, hsa-miR-4675, hsa-miR-371a, and hsa-miR-6885 were detected to have lesser than half expression to IB patients. We have analyzed the significance of these genes in relation to overall survival of 409 BC patients retrieved from the Cancer Genome Atlas data set. All available cutoff values between the lower and upper quartiles of expression are used for the selected genes, and false discovery rate using the Benjamini-Hochberg method is computed to correct for multiple hypothesis testing. We have run combined survival analysis of the mean expression of these four miRNAs highly expressed in FBS patients. 175 patients with high expression had a longer median survival of 98.47 months than 23.73 months in 233 patients with low expression (hazard ratio [HR]: 0.53; 0.39–0.72, log-rank p value: 7.3e−0.5). Combination analysis of all 8 genes including hsa-miR-6835, hsa-miR-4675, hsa-miR-371a, and hsa-miR-6885 showed the same HR for OS. Target scanning for these miRNAs matched specific cytokines known as an early biomarker to develop radiation-induced fibrosis. Conclusions: BC patients with fibrotic radiation injury have specific miRNA expression profile targeting profibrotic cytokines and these miRNAs possibly render to favorable survival. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Optimizing Advanced Imaging of the Pediatric Patient in the Emergency Department: Technical Report.
- Author
-
Marin, Jennifer R., Lyons, Todd W., Claudius, Ilene, Fallat, Mary E., Aquino, Michael, Ruttan, Timothy, and Daugherty, Reza J.
- Subjects
- *
DIAGNOSTIC imaging , *RADIOLOGIC technology , *HEALTH policy , *CLINICAL decision support systems , *RADIATION injuries , *EMERGENCY medical services , *DECISION making in clinical medicine , *ULTRASONIC imaging , *MAGNETIC resonance imaging , *DECISION making , *PEDIATRICS - Abstract
Advanced diagnostic imaging modalities, including ultrasonography, computed tomography, and magnetic resonance imaging, are key components in the evaluation and management of pediatric patients presenting to the emergency department. Advances in imaging technology have led to the availability of faster and more accurate tools to improve patient care. Notwithstanding these advances, it is important for physicians, physician assistants, and nurse practitioners to understand the risks and limitations associated with advanced imaging in children and to limit imaging studies that are considered low value, when possible. This technical report provides a summary of imaging strategies for specific conditions where advanced imaging is commonly considered in the emergency department. As an accompaniment to the policy statement, this document provides resources and strategies to optimize advanced imaging, including clinical decision support mechanisms, teleradiology, shared decision-making, and rationale for deferred imaging for patients who will be transferred for definitive care. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Global Consensus Recommendations on Improving the Safety of Chronic Total Occlusion Interventions.
- Author
-
Wu, Eugene B., Kalyanasundaram, Arun, Brilakis, Emmanouil S., Mashayekhi, Kambis, and Tsuchikane, Etsuo
- Subjects
- *
CHRONIC total occlusion , *PERCUTANEOUS coronary intervention , *ARTERIAL catheterization , *RADIATION injuries , *ACUTE kidney failure - Abstract
Safety is of critical importance to chronic total occlusion (CTO) percutaneous coronary intervention (PCI). This global consensus statement provides guidance on how to optimise the safety of CTO) PCI, addressing the following 12 areas: 1. Set-up for safe CTO PCI; 2. Guide catheter-–associated vessel injuries; 3. Hydraulic dissection, extraplaque haematoma expansion, and aortic dissections; 4. Haemodynamic collapse during CTO PCI; 5. Side branch occlusion; 6. Perforations; 7. Equipment entrapment; 8. Vascular access considerations; 9. Contrast-induced acute kidney injury; 10. Radiation injury; 11 When to stop; and, 12. Proctorship. This statement complements the global CTO crossing algorithm; by advising how to prevent and deal with complications, this statement aims to facilitate clinical practice, research, and education relating to CTO PCI. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Evaluation of the protective effect of coenzyme Q10 against x‐ray irradiation‐induced ovarian injury.
- Author
-
Tekin, Yesim Bayoglu, Tumkaya, Levent, Mercantepe, Tolga, Topal, Zehra Suzan, Samanci, Tuğba Celik, Yilmaz, Hulya Kilic, Rakici, Sema, and Topcu, Atilla
- Subjects
- *
THERAPEUTIC use of antioxidants , *THERAPEUTIC use of ubiquinones , *RESEARCH funding , *RADIATION injuries , *TREATMENT effectiveness , *DESCRIPTIVE statistics , *OXIDATIVE stress , *RATS , *ANIMAL experimentation , *RESEARCH , *STAINS & staining (Microscopy) , *OVARIES , *MALONDIALDEHYDE - Abstract
Aim: This study focused on the anti‐oxidant and anti‐apoptotic effects of CoQ10 in ovaries exposed to pelvic radiation. Methods: Thirty‐two female rats were randomly assigned into four groups. Group I (control group), Group II: Only 2 Gy pelvic x‐ray irradiation (IR) was administered as a single fractioned dose. Group III: 30 mg/kg CoQ10 was administered by oral gavage +2 Gy pelvic IR. Group IV: 150 mg/kg CoQ10 was administered by oral gavage +2 Gy pelvic IR. CoQ10 treatment was started 7 days before pelvic IR and completed 7 days later. The rats in Group III and IV were treated with CoQ10 for a total of 14 days. Results: Histopathological analysis showed severe damage to the ovarian tissue in the radiation group, while both doses of CoQ10 showed normal histological structure. Likewise, while there was a high level of staining in the IR group for necrosis and apoptosis, the CoQ10 treated ones were like the control group. Tissue Malondialdehyde (MDA) levels were like the control group in the low‐dose CoQ10 group, while the MDA levels of the high dose CoQ10 group were similar to the radiation group. Conclusion: Usage of low‐dose CoQ10 has a radioprotective effect on radiation‐induced ovarian damage. Although the use of high doses is morphologically radioprotective, no antioxidative effect was observed in the biochemical evaluation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Characterizing Proton-Induced Biological Effects in a Mouse Spinal Cord Model: A Comparison of Bragg Peak and Entrance Beam Response in Single and Fractionated Exposures.
- Author
-
Denbeigh, Janet M., Howard, Michelle E., Garcia, Darwin A., Debrot, Emily K., Cole, Kristin C., Remmes, Nicholas B., and Beltran, Chris J.
- Subjects
- *
SPINAL cord , *LINEAR energy transfer , *CERVICAL cord , *RADIATION injuries , *LABORATORY mice , *MICE , *CERVICAL spondylotic myelopathy - Abstract
Proton relative biological effectiveness (RBE) is a dynamic variable influenced by factors like linear energy transfer (LET), dose, tissue type, and biological endpoint. The standard fixed proton RBE of 1.1, currently used in clinical planning, may not accurately represent the true biological effects of proton therapy (PT) in all cases. This uncertainty can contribute to radiation-induced normal tissue toxicity in patients. In late-responding tissues such as the spinal cord, toxicity can cause devastating complications. This study investigated spinal cord tolerance in mice subjected to proton irradiation and characterized the influence of fractionation on proton- induced myelopathy at entrance (ENT) and Bragg peak (BP) positions. Cervical spinal cords of 8-week-old C57BL/6J female mice were irradiated with single- or multi-fractions (18x) using lateral opposed radiation fields at 1 of 2 positions along the Bragg curve: ENT (dose-mean LET = 1.2 keV/μm) and BP (LET = 6.9 keV/μm). Mice were monitored over 1 year for changes in weight, mobility, and general health, with radiation-induced myelopathy as the primary biological endpoint. Calculations of the RBE of the ENT and BP curve (RBE ENT/BP) were performed. Single-fraction RBE ENT/BP for 50% effect probability (tolerance dose (TD 50), grade II paresis, determined using log-logistic model fitting) was 1.10 ± 0.06 (95% CI) and for multifraction treatments it was 1.19 ± 0.05 (95% CI). Higher incidence and faster onset of paralysis were seen in mice treated at the BP compared with ENT. The findings challenge the universally fixed RBE value in PT, indicating up to a 25% mouse spinal cord RBE ENT/BP variation for multifraction treatments. These results highlight the importance of considering fractionation in determining RBE for PT. Robust characterization of proton-induced toxicity, aided by in vivo models, is paramount for refining clinical decision-making and mitigating potential patient side effects. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Treatment Outcome of Response-Based Radiation Therapy in Children and Adolescents With Central Nervous System Nongerminomatous Germ Cell Tumors: Results of a Prospective Study.
- Author
-
Zeng, Chenggong, Yang, Qunying, Li, Zhuoran, Wei, Zhiqing, Chen, Tingting, Deng, Meiling, Wang, Jian, Wang, Juan, Sun, Feifei, Huang, Junting, Lu, Suying, Zhu, Jia, Sun, Xiaofei, and Zhen, Zijun
- Subjects
- *
CENTRAL nervous system , *RADIOTHERAPY , *TREATMENT effectiveness , *INDUCTION chemotherapy , *REOPERATION , *GERM cell tumors , *RADIATION injuries - Abstract
The optimal dose and range of radiation therapy for central nervous system nongerminomatous germ cell tumors (NGGCTs) have not been uniformly established. Therefore, this study aimed to investigate the effect of individualized radiation therapy, based on the response to induction chemotherapy combined with surgery, on the prognosis of patients with NGGCTs. Based on the imaging examination and tumor markers after induction chemotherapy and pathologic results of second-look surgery, patients with NGGCT received different radiation therapy strategies, including 30.6 Gy whole ventricular irradiation + tumor-bed boost to 54 Gy, 30.6 Gy craniospinal irradiation + tumor-bed boost to 54 Gy, 36 Gy craniospinal irradiation + tumor-bed boost to 54 Gy, and 36 Gy craniospinal irradiation + 54 Gy tumor-bed boost with 45 Gy to metastatic spinal lesions. A total of 51 patients were enrolled between January 2015 and March 2021, with a median age of 10.3 years. The 3-year event-free survival and overall survival (OS) of the entire cohort were 70.2% ± 6.9% and 77.5% ± 6.0%, respectively. The 3-year OS of patients achieving partial response after induction chemotherapy was higher than that of patients with stable disease (P =.03) or progressive disease (P =.002). The 3-year event-free survival and OS of the 18 patients receiving 30.6 Gy whole ventricular irradiation and 54 Gy tumor-bed boost were 88.9% ± 7.4% and 94.4% ± 5.4%, respectively. The results suggest that an individualized radiation therapy strategy based on response to induction chemotherapy and surgery is a feasible and promising means of achieving reduction in dose and extent of radiation in patients while still providing good response. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Fitting the Crab Supernova with a Gamma-Ray Burst.
- Author
-
Ruffini, Remo and Sigismondi, Costantino
- Subjects
- *
ASTRONOMICAL observations , *RADIATION injuries , *ASTRONOMERS , *SUPERNOVAE , *X-rays , *GAMMA ray bursts - Abstract
Here, we reconsider the historical data, assuming a gamma-ray burst (GRB) as its source. A Supernova correlated with the GRB explains well the fading time observed by the ancient Chinese astronomers in the daytime and the nighttime, while the GRB power law explains the present X-rays and GeV emission of the Crab. On the grounds of a recent understanding of the first episode of binary-driven hypernova GRB (BDHN GRB) in terms of the collapse of a ten solar masses core, we propose the possible identification of the real Supernova event at an earlier time than Chinese chronicles. This work allows a new understanding of the significance of historical astronomical observations, including a fireball due to gamma-ray air shower observation and a plague of acute radiation syndrome, documented with several thousands of victims in the Eurasian area (Egypt, Iraq, and Syria). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Insights from CTTACC: immune system reset by cellular therapies for chronic illness after trauma, infection, and burn.
- Author
-
Bertram, Kenneth, Cox, Charles, Alam, Hasan, Lowell, Clifford, Cuschieri, Joseph, Parekkadan, Biju, and Pati, Shibani
- Subjects
- *
CELLULAR therapy , *CHRONIC diseases , *IMMUNE system , *MEDICAL care , *RADIATION injuries - Abstract
In this paper, we present a review of several selected talks presented at the CTTACC conference (Cellular Therapies in Trauma and Critical Care) held in Scottsdale, AZ in May 2023. This conference review highlights the potential for cellular therapies to "reset" the dysregulated immune response and restore physiologic functions to normal. Improvements in medical care systems and technology have increasingly saved lives after major traumatic events. However, many of these patients have complicated post-traumatic sequelae, ranging from short-term multi-organ failure to chronic critical illness. Patients with chronic critical illness have been found to have dysregulated immune responses. These abnormal and harmful immune responses persist for years after the initial insult and can potentially be mitigated by treatment with cellular therapies. The sessions emphasized the need for more research and clinical trials with cellular therapies for the treatment of a multitude of chronic illnesses: post-trauma, radiation injury, COVID-19, burns, traumatic brain injury (TBI) and other chronic infections. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Radiation-induced gastrointestinal and cutaneous injuries: understanding models, pathologies, assessments, and clinically accepted practices.
- Author
-
Tamarat, Radia, Satyamitra, Merriline M., Benderitter, Marc, and DiCarlo, Andrea L.
- Subjects
- *
RADIATION injuries , *RADIATION damage , *SKIN injuries , *PATHOLOGY , *RESEARCH personnel - Abstract
A U. S. and European joint effort fostering the development of medical countermeasures (MCMs) operable in case of radiological or nuclear emergencies. Based on the joint engagement between the U.S. National Institute of Allergy and Infectious Diseases (NIAID) and the French Institut de Radioprotection et de Sûreté Nucléaire (IRSN), a Statement of Intent to Collaborate was signed in 2014 and a series of working group meeting were established. In December 2022, the NIAID and IRSN hosted a five-day, U.S./European meeting titled 'Radiation-Induced Cutaneous and Gastrointestinal Injuries: Advances in Understanding Pathologies, Assessment, and Clinically Accepted Practices' in Paris, France. The goals of the meeting were to bring together U.S. and European investigators to explore new research avenues for the medical management of skin and gastrointestinal injuries, including specific diagnostics for each organ system, animal models, and promising medical countermeasures (MCMs) to mitigate radiation damage. There was also an emphasis on exploring additional areas of medicine and response to understand best practices from other emergency scenarios, which could be leveraged to improve radiation preparedness, and the importance of accurate dosimetry in preclinical work. Subsequent to the workshop, seven collaborative projects, funded by both organizations, were established on topics ranging from MCMs and predictive biomarkers, and using physical methods to assess cutaneous radiation injuries, to mechanistic studies to understand radiation-induced damage in multiple organ systems. The importance of accurate dosimetry in preclinical works was highlighted and two recently published U.S./European commentaries that focus on the need for dosimetry standardization in the reported literature had their origins in this meeting. This commentary summarizes the workshop and open discussions among academic investigators, industry researchers, and U.S. and IRSN program representatives. Given the substantive progress made due to these interactions, both groups plan to expand out these meetings by incorporating high-level investigators from across the globe, while endeavoring to maintain the informal setting that was conducive to in-depth scientific discussion and enhanced the state of the science in radiation research. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Post‐radiation middle ear effusion in NPC patients: Analysis of patient, tumour, and radiation factors.
- Author
-
Vainer, Igor, Tzelnick, Sharon, Kurman, Noga, Popovtzer, Aron, and Soudry, Ethan
- Subjects
- *
OTITIS media with effusion , *EUSTACHIAN tube , *MIDDLE ear , *NASOPHARYNX cancer , *RADIATION doses , *RADIATION injuries , *OTITIS media - Abstract
Objective: The purpose of this study was to investigate whether patient, tumour and radiation therapy factors are associated with development of middle ear effusion (MEE) in nasopharyngeal carcinoma (NPC) patients. Deign, Settings, and Participants: A retrospective review of NPC patients treated between January 2000 and June 2018 at Rabin Medical Center. Patient factors, tumour factors, radiation doses, and radiation fields were collected and outlined if needed (middle ear, eustachian tube [ET], tensor veli palatini [TVP], and levator palatini [LVP] muscles), then analysed and compared between patients with MEE and those without and between sides in patients with unilateral MEE. Main Outcome Measures and Results: Seventy‐three patients were enrolled. Most were males (71.2%) with advanced‐stage diseases (78%). At the time of diagnosis 14 patients (19.2%) presented with MEE. Following radiation, 18 patients, with no evidence of MEE at presentation, developed MEE. Tumour stage, histology, and laterality were not associated with development of MEE. Comparison of mean radiation field dosages including—gross target volume, clinical target volume, and patient target volume showed no association with post‐radiation MEE. In addition, no difference was found in the radiation doses to the middle ear, ET or the LVP nor the TVP between ears with and without MEE. Conclusions: Post‐irradiation MEE remains a common adverse effect in NPC patients. Surprisingly, tumour stage, tumour laterality, and histology were not associated with MEE. Similar findings were observed for total radiation doses and specific doses to the middle ear, ET, and ET muscles. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Radiation Exposure in Fluoroscopy-Guided Procedures.
- Author
-
Dyess, Christian B. and Moore, Kristi G.
- Subjects
RADIATION protection ,PERSONAL protective equipment ,RADIATION injuries ,ARTIFICIAL intelligence ,MINIMALLY invasive procedures ,INTERVENTIONAL radiology ,RADIATION doses ,FLUOROSCOPY - Abstract
The article offers information on radiation exposure in fluoroscopy-guided procedures. Topics discussed include fluoroscopy-guided minimally invasive procedures, amount of radiation that surgeons receive while performing routine fluoroscopy-guided procedures, and factors that reduce radiation exposure. Also mentioned is artificial intelligence in radiation protection.
- Published
- 2024
43. Evaluation of alterations in interstitial fluid dynamics in cases of whole‐brain radiation using the diffusion‐weighted image analysis along the perivascular space method.
- Author
-
Taoka, Toshiaki, Ito, Rintaro, Nakamichi, Rei, Nakane, Toshiki, Kawamura, Mariko, Ishihara, Shunichi, Ichikawa, Kazushige, Kawai, Hisashi, and Naganawa, Shinji
- Subjects
EXTRACELLULAR fluid ,FLUID dynamics ,DIFFUSION magnetic resonance imaging ,IMAGE analysis ,DIFFUSION tensor imaging ,RADIATION injuries - Abstract
In the current study, we assessed changes in interstitial fluid dynamics resulting after whole‐brain radiotherapy using the diffusion‐weighted image analysis along the perivascular space (DWI‐ALPS) method, which is a simplified variation of the diffusion tensor image ALPS (DTI‐ALPS) method using diffusion‐weighted imaging (DWI) with orthogonal motion‐probing gradients (MPGs). This retrospective study included 47 image sets from 22 patients who underwent whole‐brain radiotherapy for brain tumors. The data for the normal control group comprised 105 image sets from 105 participants with no pathological changes. DWI was performed with the three MPGs applied in an orthogonal direction to the imaging plane, and apparent diffusion coefficient images for the x‐, y‐, and z‐axes were retrospectively generated. The ALPS index was calculated to quantify interstitial fluid dynamics. The independent t‐test was used to compare the ALPS index between normal controls and patients who underwent whole‐brain radiotherapy. Patients were compared in all age groups and individual age groups (20–39, 40–59, and 60–84 years). We also examined the correlation between biologically equivalent doses (BEDs) and the ALPS index, as well as the correlation between white matter hyperintensity and the ALPS index. In the comparison of all age groups, the ALPS index was significantly lower (p < 0.001) in the postradiation group (1.32 ± 0.16) than in the control group (1.44 ± 0.17), suggesting that interstitial fluid dynamics were altered in patients following whole‐brain radiotherapy. Significant age group differences were found (40–59 years: p < 0.01; 60–84 years: p < 0.001), along with a weak negative correlation between BEDs (r = −0.19) and significant correlations between white matter hyperintensity and the ALPS index (r = −0.46 for periventricular white matter, r = −0.38 for deep white matter). It was concluded that the ALPS method using DWI with orthogonal MPGs suggest alteration in interstitial fluid dynamics in patients after whole‐brain radiotherapy. Further systematic prospective studies are required to investigate their association with cognitive symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Pharmacokinetic and Metabolomic Studies with a Promising Radiation Countermeasure, BBT-059 (PEGylated interleukin-11), in Rhesus Nonhuman Primates.
- Author
-
Carpenter, Alana D., Li, Yaoxiang, Wise, Stephen Y., Fatanmi, Oluseyi O., Petrus, Sarah A., Fam, Christine M., Carlson, Sharon J., Cox, George N., Cheema, Amrita K., and Singh, Vijay K.
- Subjects
MACAQUES ,METABOLOMICS ,BLOOD cell count ,PHARMACOKINETICS ,PRIMATES ,RADIATION injuries - Abstract
BBT-059, a long-acting PEGylated interleukin-11 (IL-11) analog that is believed to have hematopoietic promoting and anti-apoptotic properties, is being developed as a potential radiation medical countermeasure (MCM) for hematopoietic acute radiation syndrome (H-ARS). This agent has been shown to improve survival in lethally irradiated mice. To further evaluate the drug's toxicity and safety profile, 12 naïve nonhuman primates (NHPs, rhesus macaques) were administered one of three doses of BBT-059 subcutaneously and were monitored for the next 21 days. Blood samples were collected throughout the study to assess the pharmacokinetics (PK) and pharmacodynamics (PD) of the drug as well as its effects on complete blood counts, cytokines, vital signs, and to conduct metabolomic studies. No adverse effects were detected in any treatment group during the study. Short-term changes in metabolomic profiles were present in all groups treated with BBT-059 beginning immediately after drug administration and reverting to near normal levels by the end of the study period. Several pathways and metabolites, particularly those related to inflammation and steroid hormone biosynthesis, were activated by BBT-059 administration. Taken together, these observations suggest that BBT-059 has a good safety profile for further development as a radiation MCM for regulatory approval for human use. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Treatment of Darier Disease with Radiation Therapy: Case Report and Literature Review.
- Author
-
Liu, Xinzhou, Wang, Xiuhuan, Li, Jianke, Shan, Xiaofeng, and Shi, Zhongxiang
- Subjects
KERATOSIS follicularis ,LITERATURE reviews ,RADIATION injuries ,RADIOTHERAPY ,THERAPEUTICS ,RADIATION carcinogenesis - Abstract
Darier's disease (DD) is an autosomal dominant genodermatosis characterized by hyperkeratotic papules, often accompanied by scaling and crusting. Managing DD presents significant challenges due to the absence of an effective cure, with only symptom targeting treatments currently available. This study presents a case of refractory DD that showed poor response to established pharmacological treatments but demonstrated improvement with low-dose superficial X-ray radiotherapy (SRT). The radiation was delivered as a single 200 cGy treatment, which visibly improved the condition. Considering the different degrees of side effects, sequelae, and risk of developing radiation-induced cancer after exposure to moderate levels of radiation, it may be considered that we attempt to treat recalcitrant DD initially by applying a low dose of radiation in order to mitigate these undesired side effects. If larger doses or additional courses are necessary due to inadequate response, the risks and benefits must be carefully evaluated and discussed with patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Nigella sativa oil mitigates xerostomia and preserves salivary function in radiotherapy-treated mice.
- Author
-
Luff, Marie, Evans, Lauran, Hiyari, Sarah, Kwan, Kera, Cameron, Brian, Miller, Amanda, St John, Maie, and Alhiyari, Yazeed
- Subjects
Nigella sativa oil ,head and neck neoplasms ,radiation injuries ,salivary glands ,thymoquinone ,xerostomia - Abstract
OBJECTIVE: This study aimed to assess if Nigella sativa oil (NSO), a health supplement containing thymoquinone as a major component, can act as a protective agent in salivary gland stem cells following radiotherapy (RT) damage. METHODS: Forty, 10-week-old, male C3H/HeJ mice were randomized to four experimental groups: sham RT + H2O gavage (control) (N = 4); 15 Gy RT + H2O gavage (N = 12); sham RT + NSO gavage (N = 12); and 15 Gy RT + NSO gavage (N = 12). Weight changes, saliva production, and salivary gland histopathologic staining were recorded for each group over the course of the experiment. RESULTS: All mice in the sham RT + H2O gavage and sham RT + NSO gavage groups demonstrated 100% 60-day survival. RT + H2O compared to RT + NSO gavaged mice were significantly underweight by an average of 6.4 g (p
- Published
- 2023
47. Pelvic Radiation Disease in Childhood Cancer Survivors
- Author
-
University College London Hospitals and Great Ormond Street Hospital for Children NHS Foundation Trust
- Published
- 2023
48. Perceptions of prostate cancer patients undergoing definitive radiotherapy on the impact of prostate cancer and radiation therapy on male sexuality.
- Author
-
Daniels, Joseph, Baffoe-Krapim, Leroy, Yaw Nyantakyi, Andrew, Ayaaba Ayabilah, Edwina, Naa Odey Tackie, Judith, and Kyei, Kofi Adesi
- Subjects
- *
PROSTATE cancer patients , *PREMATURE ejaculation , *MEDICAL personnel , *RADIATION injuries , *PATIENTS' attitudes - Abstract
Introduction: Male sexual function is an important aspect of the life of prostate cancer patients and plays a significant role in the long-term quality of life of prostate cancer survivors. However, there is a paucity of published literature on the perceived impact of prostate cancer and its treatment on the sexual function of patients in Ghana and West Africa in general. The purpose of this study was to explore the perceptions of prostate cancer patients on the effects of the disease and radiation therapy on male sexual function. The study also examined the changes in sexuality experienced by men with prostate cancer. Methods: This research was a descriptive longitudinal study conducted at the third largest hospital in Africa. The study included Ghanaian prostate cancer patients of all ages who were treated with definitive radiotherapy at the study site between October 2021 and May 2022. Quantitative data were collected and analysed using the Statistical Package for Social Sciences version 26.0 and Microsoft Excel 2019. Descriptive statistics were used to determine frequencies and percentages of the demographic characteristics. Results: The mean age of the participants was 65.7 years (SD 6.7) ranging from 50 to 81 years. Patients had different ideas about the potential adverse effects of prostate cancer (86%) and radiotherapy (70%) on male sexual function. A decrease in sexual desire (54%) was the commonest perceived effect of prostate cancer on male sexual function followed by premature ejaculation (49%) and a decrease in sexual activity (48%). On the other hand, erectile dysfunction (49%) was the commonest perceived effect of radiotherapy for prostate cancer on male sexual function followed by a decrease in sexual desire (38%) and premature ejaculation (37%). Health professionals were the major source of information regarding the perceptions of the patients on the effects of both prostate cancer (46%) and radiation therapy (43%) on male sexual function. Conclusion: There should be enhancement of awareness measures to educate Ghanaian cancer patients on the side effects and implications of treatment on their sexuality. Comprehensive sexual health assessment should be incorporated in the routine care of patients with cancers that have the potential to impact the sexual function of patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Anti-ceramide Single-Chain Variable Fragment Mitigates Gastrointestinal-Acute Radiation Syndrome and Improves Marrow Reconstitution, Rendering Near-Normal 90-Day Autopsies.
- Author
-
Nagesh, Prashanth K.B., Monette, Sebastien, Shamu, Tambudzai, Giralt, Sergio, Jean, Samantha C. St., Zhang, Zhigang, Fuks, Zvi, and Kolesnick, Richard
- Subjects
- *
BONE marrow transplantation , *RADIATION injuries , *GASTROINTESTINAL system , *BONE marrow , *LABORATORY mice - Abstract
After September 11, 2001, nuclear threat prompted government agencies to develop medical countermeasures to mitigate two syndromes, the hematopoietic-acute radiation syndrome (H-ARS) and the higher-dose gastrointestinal-acute radiation syndrome (GI-ARS), both lethal within weeks. While repurposing leukemia drugs that enhance bone marrow repopulation successfully treats H-ARS, no mitigator potentially deliverable under mass casualty conditions preserves the GI tract. We recently reported that anti-ceramide single-chain variable fragment (scFv) mitigates GI-ARS lethality, abrogating ongoing small intestinal endothelial apoptosis to rescue Lgr5+ stem cells. Here, we examine long-term consequences of prevention of acute GI-ARS lethality. For these studies, C57BL/6J male mice were treated with 15 Gy whole body irradiation, the 90% GI-ARS lethal dose for this mouse strain. Mice irradiated with 15 Gy alone or with 15 Gy + bone marrow transplantation (BMT) or anti-ceramide scFv, succumb to an ARS within 8 to 10 days. Autopsies reveal only mice receiving anti-ceramide scFv at 24 hours post-whole body irradiation display small intestinal rescue. No marrow reconstitution occurs in any group with attendant undetectable circulating blood elements. Mice receiving 15 Gy + BMT + scFv, however, normalize blood counts by day 12, suggesting that scFv also improves marrow reconstitution, a concept for which we provide experimental support. We show that at 14 Gy, the upper limit dose for H-ARS lethality before transition to GI-ARS lethality, anti-ceramide scFv markedly improves marrow take, reducing the quantity of marrow-conferring survival by more than 3-fold. Consistent with these findings, mice receiving 15 Gy + BMT + scFv exhibit prolonged survival. At day 90, before sacrifice, they display normal appearance, behavior, and serum biochemistries, and surprisingly, at full autopsy, near-normal physiology in all 42 tissues examined. Anti-ceramide scFv mitigates GI-ARS lethality and improves marrow reconstitution rendering prolonged survival with near normal autopsies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Awareness of radiation hazards and knowledge of radioprotective measures among radiologists and non-radiology staff: a cross-sectional survey.
- Author
-
Fataftah, Jehad, Tayyem, Raed, Al-Dwairy, Salem, Al Manasra, Abdel Rahman, Ibrahim, Aqleh, Al Ryalat, Randa, Alwreikat, Mallak, Al-Shraah, Hebatuallah, Alharbi, Razan, and Alharbi, Banan
- Subjects
INTELLECT ,CROSS-sectional method ,PEARSON correlation (Statistics) ,T-test (Statistics) ,RADIATION injuries ,QUESTIONNAIRES ,DESCRIPTIVE statistics ,CHI-squared test ,RADIATION-protective agents ,DATA analysis software ,CONFIDENCE intervals ,COGNITION - Abstract
Background: Ionizing radiation has become increasingly utilized in medical practice. Consequently, healthcare workers must be aware of radiation hazards and apply the necessary countermeasures to reduce occupational exposure. This study assessed the awareness of radiation hazards and knowledge of radiation protection measures among radiologists and non-radiologists. These findings may improve the application of various safety measures during medical interventions involving radiation. Methods: We conducted a cross-sectional questionnaire-based study among 200 medical personnel, including consultant surgeons, physicians, radiologists, nurses, and radiographers, across five hospitals in Jordan between November 2022 and February 2023. The questionnaire collected data on demographic characteristics, awareness of radiation hazards, and knowledge of radioprotective techniques. Results: Overall, the knowledge of radiation protection and awareness of radiation hazards among the participants were poor (51.55% and 37.17%, respectively). No significant difference was detected between the medical disciplines in terms of the level of knowledge of radiation protection; however, radiographers were significantly more aware of radiation hazards. Conclusions: According to our findings, medical personnel generally have poor awareness of radiation hazards and radiation protection protocols. However, this understanding can be enhanced through periodic in-service training and regular monitoring of occupational radiation exposure by health professionals. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.